TWEAK/Fn14 signalling driven super-enhancer reprogramming promotes pro-metastatic metabolic rewiring in

Nicholas Sim1, Jean-Michel Carter1, Kamalakshi Deka1

  • 1School of Biological Sciences (SBS), Nanyang Technological University (NTU), 60 Nanyang Drive, Singapore, 637551, Singapore.

PubMed

Insights

Fibroblast growth factor-inducible 14 (Fn14) receptor is overexpressed in Triple Negative Breast Cancer (TNBC), driving tumor growth and metastasis. Targeting Fn14 signaling may offer new therapeutic strategies for TNBC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Triple Negative Breast Cancer (TNBC) is an aggressive subtype with limited treatment options.
  • Fibroblast growth factor-inducible 14 (Fn14) receptor overexpression is linked to metastasis in Estrogen Receptor (ER)-negative breast cancers.

Purpose of the Study:

  • To investigate the role of Fn14 in TNBC.
  • To elucidate the mechanisms by which Fn14 signaling contributes to TNBC progression and metastasis.
  • To identify potential therapeutic targets in TNBC.

Main Methods:

  • Analysis of Fn14 expression in TNBC patients.
  • Transcriptomic and epigenomic profiling of TNBC cells.
  • Investigation of super enhancer (SE) activity and chromatin looping.
  • Assessment of Nicotinamide phosphoribosyltransferase (NAMPT) regulation.

Main Results:

  • Fn14 is overexpressed in TNBC and associated with poor survival.
  • Fn14 signaling alters the transcriptomic and epigenomic landscape, promoting tumor growth and metastasis.
  • SEs drive upregulation of NAMPT, critical for NAD+/ATP metabolism and metastasis.

Conclusions:

  • TWEAK/Fn14 signaling is mechanistically linked to TNBC metastasis.
  • Targeting Fn14 and its downstream pathways presents potential therapeutic vulnerabilities for TNBC.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K